Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02DCM
|
|||
| Former ID |
DNC009057
|
|||
| Drug Name |
5-(3-(4-fluorobenzyl)pyrrolidin-3-yl)-1H-indole
|
|||
| Synonyms |
CHEMBL513258; 5-(3-(4-fluorobenzyl)pyrrolidin-3-yl)-1H-indole; SCHEMBL982062
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H19FN2
|
|||
| Canonical SMILES |
C1CNCC1(CC2=CC=C(C=C2)F)C3=CC4=C(C=C3)NC=C4
|
|||
| InChI |
1S/C19H19FN2/c20-17-4-1-14(2-5-17)12-19(8-10-21-13-19)16-3-6-18-15(11-16)7-9-22-18/h1-7,9,11,21-22H,8,10,12-13H2
|
|||
| InChIKey |
RBNFIIOAQFISLC-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated potassium channel Kv11.1 (KCNH2) | Target Info | Inhibitor | [1] |
| Pathwhiz Pathway | Muscle/Heart Contraction | |||
| Reactome | Voltage gated Potassium channels | |||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Hematopoietic Stem Cell Differentiation | ||||
| Potassium Channels | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6062-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.